Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Fycompa
Fycompa
With all eyes on new Alzheimer's med, Eisai lays off 91 staffers on its Fycompa team
With all eyes on new Alzheimer's med, Eisai lays off 91 staffers on its Fycompa team
Fierce Pharma
Eisai
Fycompa
layoffs
Flag link:
With bigger fish to fry, Eisai unloads US rights to epilepsy drug Fycompa to Catalyst
With bigger fish to fry, Eisai unloads US rights to epilepsy drug Fycompa to Catalyst
Fierce Pharma
Eisai
Fycompa
Catalyst Pharmaceuticals
epilepsy
Flag link:
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Fierce Pharma
FDA
drug reps
physicians
Eisai
Fycompa
drug marketing
Flag link:
Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA (perampanel) Pediatric Indications
Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA (perampanel) Pediatric Indications
CP Wire
Eisai
FDA
Fycompa
pediatric
seizures
Flag link:
Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA (perampanel) Pediatric Indications
Fycompa
Eisai
pediatric epilepsy
Flag link:
Eisai Says That the Recently Enacted IRTNMTA Should Result in a Longer PTE for FYCOMPA Patent
Eisai Says That the Recently Enacted IRTNMTA Should Result in a Longer PTE for FYCOMPA Patent
FDA Law Blog
Eisai
IRTNMTA
FDA
Fycompa
Flag link:
Drug maker loses lawsuit filed to regain ‘lost’ marketing time
Drug maker loses lawsuit filed to regain ‘lost’ marketing time
Pharmalot
Eisai
Fycompa
Belviq
FDA
DEA
market exclusivity
Flag link:
No False Starts: FDA Prevails in Eisai Challenge Over NCE Exclusivity Start Dates for BELVIQ and FYCOMPA
No False Starts: FDA Prevails in Eisai Challenge Over NCE Exclusivity Start Dates for BELVIQ and FYCOMPA
FDA Law Blog
FDA
Eisai
exclusivity
Belviq
Fycompa
Flag link:
Unfair!! Eisai Sues FDA to Regain ‘Lost’ Marketing Time for its Drugs
Unfair!! Eisai Sues FDA to Regain ‘Lost’ Marketing Time for its Drugs
WSJ Pharmalot
FDA
Eisai
Belviq
Fycompa
Flag link:
Eisai Loses Lawsuit Against DEA Over Scheduling Epilepsy Pill
Eisai Loses Lawsuit Against DEA Over Scheduling Epilepsy Pill
Pharmalot
Eisai
DEA
epilepsy
Fycompa
Flag link:
Eisai Sues DEA Over Delay In Scheduling Its Epilepsy Drug
Eisai Sues DEA Over Delay In Scheduling Its Epilepsy Drug
Pharmalot
Eisai
DEA
epilepsy
Fycompa
Flag link:
Eisai fires back at G-BA rebuff of Fycompa
Eisai fires back at G-BA rebuff of Fycompa
Fierce Pharma
Eisai
Fycompa
epilepsy
Flag link:
FDA approves Eisai's drug to treat epileptic seizures
FDA approves Eisai's drug to treat epileptic seizures
Yahoo/Reuters
FDA
Eisai
epilepsy
seizures
Fycompa
Flag link: